VYNE Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Shareholder Director Nominations, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits